$6.8 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 7 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 57.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DSEY | New | DIVERSEY HLDGS LTD | $3,476,710,000 | – | 236,350,134 | +100.0% | 51.16% | – |
| SGRY | SURGERY PARTNERS INC | $1,170,927,000 | +52.6% | 26,455,651 | 0.0% | 17.23% | -40.7% | |
| MIK | MICHAELS COS INC | $1,158,409,000 | +68.6% | 52,798,929 | 0.0% | 17.05% | -34.5% | |
| CERE | CEREVEL THERAPEUTICS HLDNG, INC. | $832,482,000 | -17.2% | 60,632,356 | 0.0% | 12.25% | -67.8% | |
| IQV | IQVIA HLDGS INC | $119,261,000 | +7.8% | 617,484 | 0.0% | 1.76% | -58.1% | |
| ADV | ADVANTAGE SOLUTIONS INC | $34,131,000 | -10.3% | 2,890,000 | 0.0% | 0.50% | -65.2% | |
| New | ATENTO S A | $3,286,000 | – | 156,574 | +100.0% | 0.05% | – | |
| ATTO | Exit | ATENTO S A | $0 | – | -156,574 | -100.0% | -0.08% | – |
| VRTV | Exit | VERITIV CORP | $0 | – | -1,383,840 | -100.0% | -1.09% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bain Capital Partners X, L.P. #1
- Bain Capital Fund X, L.P. #2
- Bain Capital Integral Investors 2008, L.P. #3
- Bain Capital Partners Europe III, L.P. #4
- Bain Capital Europe Fund III, L.P. #5
- Bain Capital Integral Investors 2006, LLC #6
- Atalaya Luxco S.a.r.l. #7
- Atalaya Luxco Topco S.C.A. #8
- Atalaya PIKco S.a r.l. #9
- Atalaya Luxco PIKco S.C.A #10
- BCPE Seminole GP LLC #11
- BCPE Seminole Holdings LP #12
- Bain Capital Partners XII, LLC #13
- Bain Capital Fund XII, LP #14
- BCPE Perception GP, LLC #15
- BC Perception Holdings, LP #16
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICHAELS COS INC | 27 | Q1 2021 | 45.7% |
| GENPACT LIMITED | 26 | Q3 2019 | 43.3% |
| VERITIV CORP | 26 | Q4 2020 | 7.1% |
| SURGERY PARTNERS INC | 25 | Q3 2023 | 54.6% |
| ATENTO S A | 25 | Q4 2020 | 14.1% |
| BRIGHT HORIZONS FAM SOL IN D | 19 | Q4 2017 | 18.4% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 15.1% |
| IQVIA HLDGS INC | 16 | Q3 2021 | 17.2% |
| VONAGE HLDGS CORP | 13 | Q2 2016 | 0.0% |
| CEREVEL THERAPEUTICS HLDNG, INC. | 12 | Q3 2023 | 42.1% |
View BAIN CAPITAL INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-21 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-18 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-07-06 |
| 4 | 2023-06-12 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2022-11-23 |
View BAIN CAPITAL INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.